COVID-19 Trends of the Day

A Short Cut way for you to Stay updated with COVID related information. Watch this space for Daily Updates

9 Likes

LikeAnswersShare

*Himalayan Barnush - scientifically known as "red Rhododendron arboreum" - hot water extract from the petals in a concentration of 1mg/ml incubated with cells infected with covid for 48 hours showed inhibition of virus multiplication by 80% --> that is quite an encouraging result. The research was also published in Biomolecular Structure and Dynamics journal. Congratulations to the team of biologist Shyam Kumar Masakapalli of School of Basic Science at IIT Mandi. Thank you for your hard work. 🙏 * Lagevrio is Molnupiravir and Paxlovid is nirmatrelvir+ritonavir. Good thing that these have been labelled as prescription drugs lest the public starts misusing and overdosing. They are to be used 12 hourly for 5 days for people with mild to moderate COVID-19 who have a high risk of progressing to severe disease. Molnupiravir is currently available in India and has been approved for the treatment of adult patients with Covid-19 and with oxygen saturation greater than 93% and who have a high risk of progression of the disease including hospitalization or death. As per a report on Jan 06, 2022, Pfizer may offer its Covid antiviral drug Paxlovid at lower prices for low and middle income countries (LMICs), including India, as an interim measure as the cheaper generic versions may not be available until later this year. * An additional point to note is that despite the US FDA's EUA approval - our ICMR and Indian Government have not included Molnupiravir in the latest guidelines for Covid treatment due to "safety concerns". ---- AVAILABILITY IN INDIA: * Molnupiravir is available in India as: - Molnutor by Torrent Pharma - Cipmolnu by Cipla - Molxvir by Sun Pharma - Molnulup by Lupin - Molnaflu by Aurobindo Pharma - Movfor by Hetero Healthcare - Molaz by Azista and so on. * Paxlovid (nirmatrelvir + ritonavir) will soon be available by same name by Pfizer itself. Since its approval by US FDA, the high income have bought most of the supply in advance. The generic form of the drug combination will most likely be available by the end of 2022 but the commercial version should be available sooner.

Good update . A lots of pills and treatment are being observed till date but none of them is revolutionary .

Nice informative and educative updates Any pathy is well come to fight corona presently only sympathy is the only way to fight corona. Waiting for really a good and effective updates . Thanks

Thanks Dr Vijay kumar singh
1

View 1 other reply

Very good informative Updated..

Nice post

Good information upto the date

Updates 1 wellcome development if Ayurved can give us a alternative weapon to fight with corna Details may be shared we will be happy to use and proud of our own pathy to follow 2 approval from f two pills paxlovid and Lageviro for provisional use for high risk pts Well it is in trial and yet we are waiting for documentation but good to carry on

Thanx dr Ashok Leel
0

View 5 other replies

COVID-19 TRENDS OF THE DAY 1:- BIOLOGISTS AT IIT MANDI HAVE FOUND A HIMALAYAN FLOWERING TREE THAT CONTAINS ANTIVIRAL PROPERTIES. EXPERIMENTS HAD SHOWN A PROMISING RESULTS. 2:- THE ORAL TREATMENTS, PAXLOVID AND LAGEVRIO , HAVE BEEN PROVISIONALLY APPROVED FOR ADULTS WHO CATCH THE VIRUS AND WHO ARE AT THE RISK OF HOSPITALIZATION OR DEATH. BOTH MEDICINES ARE TAKEN TWICE A DAY FOR FIVE DAYS .

Helpful

Thank you @Dr. Vijay Kumar Singh sir
2

View 2 other replies

Nice update

Load more answers

Diseases Related to Discussion

Covid
Corona

Cases that would interest you